# Johnson & johnson — media coverage

Johnson & johnson was mentioned 59 times in 19 outlets across 4 countries over the last 12 months. 75% of that coverage was positive and 15% negative.

- Data as of: 2026-10-04 (window: last 365 days)
- Mentions (12 months): 59 (61 all-time)
- Outlets (12 months): 19 in 4 countries
- Average sentiment: +0.435 (75% positive, 15% negative)
- Sector: Pharma
- Also written as: J&J, JnJ

## Coverage over time (mentions per month)

| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 0 |
| 2026-01 | 0 |
| 2026-02 | 1 |
| 2026-03 | 1 |
| 2026-04 | 3 |
| 2026-05 | 6 |
| 2026-06 | 7 |
| 2026-07 | 9 |
| 2026-08 | 32 |
| 2026-09 | 0 |
| 2026-10 | 0 |

## Top outlets (12 months)

| Outlet | Mentions |
|---|---|
| finance.yahoo.com | 24 |
| fool.com | 7 |
| trefis.com | 7 |
| gurufocus.com | 4 |
| thecentersquare.com | 3 |
| 247wallst.com | 1 |
| ad-hoc-news.de | 1 |
| asbestos.com | 1 |

## Countries (12 months)

| Country | Mentions |
|---|---|
| INT | 56 |
| AE | 1 |
| DE | 1 |
| US | 1 |

## Share of voice among Pharma peers (12 months)

| Brand | Mentions |
|---|---|
| Eli lilly | 130 |
| Astrazeneca | 78 |
| Pfizer | 64 |
| Johnson & johnson | 59 |
| Novo nordisk | 46 |
| Merck | 44 |
| Sandoz | 41 |
| Moderna | 38 |
| Bayer | 36 |
| Roche | 36 |

## Recent coverage

- [Johnson & Johnson to Host Q3 Earnings Call on Oct 13 - scanx.trade](https://scanx.trade/stock-market-news/companies/johnson-johnson-host-q3-earnings-call-oct-13/49756453) — scanx.trade, 2026-08-31, neutral
- [Is JNJ Overvalued? DCF Says Worth $124 - GuruFocus](https://www.gurufocus.com/news/9059792/is-jnj-overvalued-dcf-says-worth-124) — gurufocus.com, 2026-08-31, positive
- [Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. - The Motley Fool](https://www.fool.com/investing/2026/08/31/johnson-johnson-owns-stakes-in-15-stocks-heres-the/) — fool.com, 2026-08-31, positive
- [Johnson & Johnson stock holds above $268 after FDA win - ad-hoc-news.de](https://www.ad-hoc-news.de/boerse/news/corporate-news/johnson-and-johnson-stock-holds-above-268-after-fda-win/70026895) — ad-hoc-news.de, 2026-08-31, positive
- [NAVN, JNJ, CRWD Stocks Hit 52-Week Highs Last Week: What's Driving The Surge? - Stocktwits](https://stocktwits.com/news-articles/markets/equity/navn-jnj-crwd-stocks-hit-52-week-highs-last-week-what-s-driving-the-surge/cZmKzcAR7kn) — stocktwits.com, 2026-08-30, positive
- [AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool](https://www.fool.com/coverage/better-buy/2026/08/29/abbvie-vs-johnson-johnson-which-healthcare-stock-is-a-better-buy-in-2026/) — fool.com, 2026-08-29, neutral
- [Johnson & Johnson Stock: Is JNJ Outperforming the Consumer Staples Sector? - Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/johnson-johnson-stock-jnj-outperforming-171212270.html) — finance.yahoo.com, 2026-08-29, positive
- [JNJ Looks 39.1% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocus](https://www.gurufocus.com/news/9058642/jnj-looks-391-overvalued-on-gf-value-as-dividend-sustainability-remains-key) — gurufocus.com, 2026-08-28, neutral

Data: VoilàIQ, 2026-10-04. Canonical: https://voilaiq.com/brand-catalog/johnson-johnson